Concepedia

Lingjiao Zou

LZ

Statistics

Publications

5

Citations

219

H-Index

5

Active since

2018

Affiliations

Guangzhou Institutes of Biomedicine and Health(Current)

Guangzhou Medical University

University of Chinese Academy of Sciences

Jilin University

University of California, Davis

Lingjiao Zou is an author at Guangzhou Institutes of Biomedicine and Health specializing in drug discovery, pharmacotherapy, and medicine.

Top concepts

Publications per year

2018–2021

5

Publications

5

Structure-Based Discovery and Optimization of Benzo[<i>d</i>]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC)

Maofeng Zhang, Yan Zhang, Ming Song et al. · Journal of Medicinal Chemistry · 2018 · 60 citations · Full text

Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer

Lingjiao Zou, Qiuping Xiang, Xiaoqian Xue et al. · Acta Pharmacologica Sinica · 2019 · 47 citations · Full text

, , +8

Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer

Qiuping Xiang, Chao Wang, Tianbang Wu et al. · Journal of Medicinal Chemistry · 2021 · 47 citations · Full text

Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer

Yan Zhang, Xishan Wu, Xiaoqian Xue et al. · Journal of Medicinal Chemistry · 2019 · 38 citations · Full text

Benzoxazinone-containing 3,5-dimethylisoxazole derivatives as BET bromodomain inhibitors for treatment of castration-resistant prostate cancer

Xiaoqian Xue, Yan Zhang, Chao Wang et al. · European Journal of Medicinal Chemistry · 2018 · 27 citations · Full text

, , +11

1–5 of 5